References of "De Tullio, Pascal"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailRecent advances in inducible cyclooxygenase (COX-2) inhibition
De Leval, X.; Delarge, J.; Somers, F. et al

in Current Medicinal Chemistry (2000), 7(10), 1041-1062

Cyclooxygenase is the key enzyme in the biosynthesis of prostanoids, biologically active substances that are involved in several physiological processes but also in pathological conditions such as ... [more ▼]

Cyclooxygenase is the key enzyme in the biosynthesis of prostanoids, biologically active substances that are involved in several physiological processes but also in pathological conditions such as inflammation. Since ten years now, it is well known that this enzyme exists under two forms: a constitutive (COX-1) and an inducible form (COX-2). Both enzymes are sensitive to inhibition by conventional nonsteroidal anti-inflammatory drugs (NSAIDs). Observations that COX-1, involved in several homeostatic processes, played a housekeeping role while COX-2 expression was associated with inflammation and other pathologies such as cancer proliferation have led to the development of COX-2 selective inhibitors in order to reduce the classical side-effects, of which gastric irritation is the most common, associated with the use of conventional NSAIDs. [less ▲]

Detailed reference viewed: 17 (3 ULg)
Peer Reviewed
See detailEffect on the pancreatic endocrine system of 3-alkylamino-7-chloro-4H-1,2,4-benzothiadiazine 1,1-dioxides structurally related to diazoxide
Boverie, S.; Antoine, M.-H.; Becker, B. et al

in Pflügers Archiv : European Journal of Physiology (2000), 439

Detailed reference viewed: 3 (0 ULg)
Peer Reviewed
See detail7-Substituted alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as new analogues of diazoxide: effects on the insulin releasing process in vitro
Boverie, S.; Somers, F.; Ouedraogo, R. et al

in Fundamental & Clinical Pharmacology (2000), 14

Detailed reference viewed: 6 (2 ULg)
Full Text
Peer Reviewed
See detailTherapeutic and chemical developments of cholecystokinin receptor ligands
De Tullio, Pascal ULg; Delarge, J.; Pirotte, Bernard ULg

in Exp. Opin. Invest. Drugs (2000), 9

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailSynthesis and biological effects of new 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides on insulin-secreting cells
Somers, F.; De Tullio, Pascal ULg; Boverie, S. et al

in Pharmacy and Pharmacology Communications (2000), 6

Detailed reference viewed: 6 (0 ULg)
See detail1,2,4-Benzothiadiazine derivatives, their preparation and use
De Tullio, Pascal ULg; Nielsen, F. E.; Hansen, J. B. et al

Patent (1999)

Detailed reference viewed: 88 (4 ULg)
See detailPyrido 1,2,4-thiadiazine derivatives, their preparation and use
De Tullio, Pascal ULg; Boverie, S.; Somers, F. et al

Patent (1999)

Detailed reference viewed: 4 (0 ULg)